samarium has been researched along with Osteolysis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bares, R; Dohmen, BM; Einsele, H; Kanz, L; Knop, S | 1 |
| Coleman, RE | 1 |
| Fu, Z; Lei, XH; Shi, B | 1 |
1 review(s) available for samarium and Osteolysis
| Article | Year |
|---|---|
How can we improve the treatment of bone metastases further?
Topics: Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Estrogen Antagonists; Female; Forecasting; Humans; Male; Multiple Myeloma; Osteolysis; Osteoporosis; Pain; Palliative Care; Prostatic Neoplasms; Quality of Life; Radioisotope Teletherapy; Randomized Controlled Trials as Topic; Samarium | 1998 |
2 other study(ies) available for samarium and Osteolysis
| Article | Year |
|---|---|
153 Samarium-EDTMP in myeloablative dosage followed by a second autotransplantation in patients with relapsed multiple myeloma.
Topics: Fatal Outcome; Graft Survival; Humans; Male; Melphalan; Multiple Myeloma; Organometallic Compounds; Organophosphorus Compounds; Osteolysis; Peripheral Blood Stem Cell Transplantation; Radioisotopes; Radiopharmaceuticals; Salvage Therapy; Samarium; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2004 |
[Inhibitory effect of samarium-153-labeled ethylenediaminetetramethylene phosphonate (EDTMP) on bone invasion and osteolysis in Walker 256 carcinoma bearing rats].
Topics: Animals; Bone Neoplasms; Carcinoma 256, Walker; Male; Neoplasm Invasiveness; Organometallic Compounds; Organophosphorus Compounds; Osteolysis; Radioisotopes; Rats; Samarium; Tibia | 1997 |